Award Program Details
Up to 10 Harrington Rare Disease Scholars will be selected.
The award includes:
- $150,000 guaranteed, opportunity to qualify for up to $1,000,000
- Drug development expertise and project management support through the Harrington Discovery Institute’s Innovation Support Center
- Facilitated access to Takeda’s research and development experts
- Dedicated pharma team provided for each scholar
- Business and commercialization assessment
- Clinical development strategy
- Regulatory guidance
- Intellectual property review and strategy
- Access to contract research organizations/service providers
Harrington Discovery Institute and its Innovation Support Center team will work closely with awardees and their affiliated institutions to maximize the clinical and commercial potential of selected projects.
Scholars and their institutions will retain rights to intellectual property relevant to project funded in this program.
What We Fund
The Harrington Rare Disease Scholar Award selection committee seeks breakthrough discovery defined by innovation, creativity and potential clinical impact, including:
- Discoveries deemed to address unmet medical needs
- Modulators of novel and/or druggable targets
- Potential to be developed into a commercial program
- Strong intellectual property (IP) or protection strategy
- Small molecule, peptides or biologics
Applicant Eligibility Requirements
To be eligible for the award, an applicant must meet the following requirements:
- Academic investigators on faculty at accredited medical centers, research institutions and universities in the U.S. only
- Lead investigator must have a PhD or MD (or equivalent)
- Past recipients of Harrington Scholar awards may submit new and distinct proposals, but may not seek additional support for previously funded projects
Curriculum vitae for the Principal Investigator (PI) and all co-PIs must accompany the Letter of Intent. No specific format is required, but the NIH biosketch format is encouraged.
Submission will be completed online at HarringtonDiscovery.SmartSimple.com.
Late submissions will not be accepted.